Raimon Sabaté studied Pharmacy at the University of Barcelona from where he received his PhD in Pharmacy, in the field of Physical Chemistry. He subsequently went to the Institut de Biochimie et Génétique Cellulaires (IBGC - CNRS) in Bordeaux (France) with a MEC-Fulbright grant. He then returned to Barcelona, at the Institut de Biotecnologia i de Biomedicina (IBB - UAB), thanks to a Beatriu de Pinós postdoctoral fellowship. After this fruitful postdoctoral period, during which he was trained in different areas, viz. from chemical physics and biophysics to biochemistry, molecular biology and neurosciences, in 2012, he was awarded with a Ramón y Cajal position at the University of Barcelona (UB). He created the Conformational Diseases Group, in the Department of Physical Chemistry of the Faculty of Pharmacy at the UB that he is leading as an Associate Professor.
He is a biochemist experienced in the study of amyloid aggregation and conformational diseases, such as Alzheimer’s disease, Parkinson’s disease and spongiform encephalopathy and other prion and prion-like diseases.
He recently developed new fast, simple, and cheap methods to screen potential inhibitors of amyloid aggregation, which use prokaryotic and eukaryotic models (bacteria or yeast and fungus). These tests are much more rapid and cost-effective than in vivo
studies with transgenic animals.